Pervasive roles of microRNAs in cardiovascular biology

Nature

Volumn 469, Issue 7330, 2011, Pages 336-342

  Small, Eric M ^a   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; OLIGONUCLEOTIDE;

CARDIOLOGY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; FLY; FUTURE PROSPECT; RNA;

BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENETIC MANIPULATION; HEART DEVELOPMENT; HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

ANIMALS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; MICRORNAS; MUTATION;

MAMMALIA;

EID: 78751660177     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature09783     Document Type: Review

References (91)

1. Hill, J. A. & Olson, E. N. Cardiac plasticity. N. Engl. J. Med. 358, 1370-1380 (2008).
2. Hoffman, J. I. & Kaplan, S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 39, 1890-1900 (2002).
3. Bruneau, B. G. The developmental genetics of congenital heart disease. Nature 451, 943-948 (2008).
4. Cordes, K. R. & Srivastava, D. MicroRNA regulation of cardiovascular development. Circ. Res. 104, 724-732 (2009).
5. Latronico, M. V. & Condorelli, G. MicroRNAs and cardiac pathology. Nature Rev. Cardiol. 6, 419-429 (2009).
6. Small, E. M., Frost, R. J. & Olson, E. N. MicroRNAs add a new dimension to cardiovascular disease. Circulation 121, 1022-1032 (2010).
7. Van Rooij, E. & Olson, E. N. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J. Clin. Invest. 117, 2369-2376 (2007).
8. Liu, N. & Olson, E. N. MicroRNA regulatory networks in cardiovascular development. Dev. Cell 18, 510-525 (2010).
9. Ikeda, S. et al. Altered microRNA expression in human heart disease. Physiol. Genomics 31, 367-373 (2007).
10. Van Rooij, E. et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl Acad. Sci. USA 103, 18255-18260 (2006).
11. Matkovich, S. J. et al. Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 119, 1263-1271 (2009).
12. Thum, T. et al. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116, 258-267 (2007).
13. Roy, S. et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res. 82, 21-29 (2009).
14. Van Rooij, E. et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl Acad. Sci. USA 105, 13027-13032 (2008).
15. Ji, R. et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ. Res. 100, 1579-1588 (2007).
16. Xin, M. et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 23, 2166-2178 (2009).
17. Huang, Z. P., Neppl, R. L. & Wang, D. Z. MicroRNAs in cardiac remodeling and disease. J. Cardiovasc. Transl. Res. 3, 212-218 (2010).
18. Van Rooij, E., Marshall, W. S. & Olson, E. N. Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circ. Res. 103, 919-928 (2008).
19. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
20. Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nature Rev. Genet. 9, 102-114 (2008).
21. Bartel, D. P. MicroRNAs: genomics, Biogenesis, Mechanism, And function. Cell 116, 281-297 (2004).
22. Lutter, D., Marr, C., Krumsiek, J., Lang, E. W. & Theis, F. J. Intronic microRNAs support their host genes by mediating synergistic and antagonistic regulatory effects. BMC Genomics 11, 224 (2010).
23. Cao, G. et al. Intronic miR-301 feedback regulates its host gene, Ska2, In A549 cells by targeting MEOX2 to affect ERK/CREB pathways. Biochem. Biophys. Res. Commun. 396, 978-982 (2010).
24. Najafi-Shoushtari, S. H. et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328, 1566-1569 (2010).
25. Poliseno, L. et al. Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci. Signal. 3, Ra29 (2010).
26. Barik, S. An intronic microRNA silences genes that are functionally antagonistic to its host gene. Nucleic Acids Res. 36, 5232-5241 (2008).
27. Alvarez-Saavedra, E. & Horvitz, H. R. Many families of C. Elegans microRNAs are not essential for development or viability. Curr. Biol. 20, 367-373 (2010).
28. Ambros, V. MicroRNAs: genetically sensitized worms reveal new secrets. Curr. Biol. 20, R598-R600 (2010).
29. Brenner, J. L., Jasiewicz, K. L., Fahley, A. F., Kemp, B. J. & Abbott, A. L. Loss of individual microRNAs causes mutant phenotypes in sensitized genetic backgrounds in C. Elegans. Curr. Biol. 20, 1321-1325 (2010).
30. Zhao, Y. et al. Dysregulation of cardiogenesis, Cardiac conduction, And cell cycle in mice lacking miRNA-1-2. Cell 129, 303-317 (2007).
31. Yang, B. et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nature Med. 13, 486-491 (2007).
32. Luo, X. et al. Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J. Biol. Chem. 283, 20045-20052 (2008).
33. Small, E. M. et al. Regulation of PI3-kinase/Akt signalling by muscle-enriched microRNA-486. Proc. Natl Acad. Sci. USA 107, 4218-4223 (2010).
34. Xu, N., Papagiannakopoulos, T., Pan, G., Thomson, J. A. & Kosik, K. S. MicroRNA-145 regulates OCT4, SOX2, And KLF4 and represses pluripotency in human embryonic stem cells. Cell 137, 647-658 (2009).
35. Choi, W. Y., Giraldez, A. J. & Schier, A. F. Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318, 271-274 (2007).
36. Xiao, J. et al. Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J. Cell. Physiol. 212, 285-292 (2007).
37. Brown, B. D. & Naldini, L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nature Rev. Genet. 10, 578-585 (2009).
38. Ebert, M. S., Neilson, J. R. & Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nature Methods 4, 721-726 (2007).
39. Chen, J. F. et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc. Natl Acad. Sci. USA 105, 2111-2116 (2008).
40. Albinsson, S. et al. MicroRNAs are necessary for vascular smooth muscle growth, Differentiation, And function. Arterioscler. Thromb. Vasc. Biol. 30, 1118-1126 (2010).
41. Rao, P. K. et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ. Res. 105, 585-594 (2009). Deep sequencing showed that the 18 most abundant cardiac miRNAs account for more than 90% of all miRNAs in the heart.
42. Brown, B. D. et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, Lineage and differentiation state. Nature Biotechnol. 25, 1457-1467 (2007).
43. Liu, N. et al. An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc. Natl Acad. Sci. USA 104, 20844-20849 (2007).
44. Zhao, Y., Samal, E. & Srivastava, D. Serum response factor regulates a musclespecific microRNA that targets Hand2 during cardiogenesis. Nature 436, 214-220 (2005).
45. Ivey, K. N. et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2, 219-229 (2008).
46. Liu, N. et al. MicroRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 22, 3242-3254 (2008).
47. Deacon, D. C. et al. The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis. Development 137, 1887-1896 (2010).
48. Morton, S. U. et al. MicroRNA-138 modulates cardiac patterning during embryonic development. Proc. Natl Acad. Sci. USA 105, 17830-17835 (2008).
49. Schmidt, M. et al. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development 134, 2913-2923 (2007).
50. Nicoli, S. et al. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 464, 1196-1200 (2010).
51. Kuhnert, F. et al. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135, 3989-3993 (2008).
52. Wang, S. et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261-271 (2008).
53. Fish, J. E. et al. MiR-126 regulates angiogenic signalling and vascular integrity. Dev. Cell 15, 272-284 (2008).
54. Small, E. M., Sutherland, L. B., Rajagopalan, R., Wang, S. & Olson, E. N. MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. Circ. Res. 107, 1336-1344 (2010).
55. Cordes, K. R. et al. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460, 705-710 (2009).
56. Elia, L. et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ. 16, 1590-1598 (2009).
57. Boettger, T. et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 119, 2634-2647 (2009).
58. Zhao, G., Yu, D. & Weiss, M. J. MicroRNAs in erythropoiesis. Curr. Opin. Hematol. 17, 155-162 (2010).
59. Georgantas, R. W. III et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl Acad. Sci. USA 104, 2750-2755 (2007).
60. O'Carroll, D. et al. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev. 21, 1999-2004 (2007).
61. Lu, J. et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev. Cell 14, 843-853 (2008).
62. Wang, Q. et al. MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 111, 588-595 (2008).
63. Rasmussen, K. D. et al. The miR-144/451 locus is required for erythroid homeostasis. J. Exp. Med. 207, 1351-1358 (2010).
64. Johnnidis, J. B. et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125-1129 (2008).
65. Patrick, D. M. et al. Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3ζ. Genes Dev. 24, 1614-1619 (2010).
66. Yu, D. et al. MiR-451 protects against erythroid oxidant stress by repressing 14-3-3ζ. Genes Dev. 24, 1620-1633 (2010).
67. Callis, T. E. et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 119, 2772-2786 (2009).
68. Thum, T. et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984 (2008).
69. Van Rooij, E. et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579 (2007).
70. Care, A. et al. MicroRNA-133 controls cardiac hypertrophy. Nature Med. 13, 613-618 (2007).
71. Van Rooij, E. et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell 17, 662-673 (2009).
72. Molkentin, J. D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228 (1998).
73. Lin, Z. et al. MiR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc. Natl Acad. Sci. USA 106, 12103-12108 (2009).
74. Rane, S. et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1α and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ. Res. 104, 879-886 (2009).
75. Patrick, D. M. et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Invest. 120, 3912-3916 (2010).
76. Fleissner, F. et al. Asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism. Circ. Res. 107, 138-143 (2010).
77. Bonauer, A. et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324, 1710-1713 (2009).
78. Van Solingen, C. et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J. Cell. Mol. Med. 13, 1577-1585 (2009).
79. Zernecke, A. et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2, Ra81 (2009).
80. Harris, T. A., Yamakuchi, M., Ferlito, M., Mendell, J. T. & Lowenstein, C. J. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc. Natl Acad. Sci. USA 105, 1516-1521 (2008).
81. Cheng, Y. et al. MicroRNA-145, A novel smooth muscle cell phenotypic marker and modulator, Controls vascular neointimal lesion formation. Circ. Res. 105, 158-166 (2009).
82. Saunders, M. A., Liang, H. & Li, W. H. Human polymorphism at microRNAs and microRNA target sites. Proc. Natl Acad. Sci. USA 104, 3300-3305 (2007). (Pubitemid 46364154)
83. Chen, K. & Rajewsky, N. Natural selection on human microRNA binding sites inferred from SNP data. Nature Genet. 38, 1452-1456 (2006).
84. Clop, A. et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nature Genet. 38, 813-818 (2006).
85. Sethupathy, P. et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am. J. Hum. Genet. 81, 405-413 (2007).
86. Schipper, M. E., Van Kuik, J., De Jonge, N., Dullens, H. F. & de Weger, R. A. Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support. J. Heart Lung Transplant. 27, 1282-1285 (2008).
87. Voellenkle, C. et al. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol. Genomics 42, 420-426 (2010).
88. Fichtlscherer, S. et al. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107, 677-684 (2010).
89. Ji, X. et al. Plasma miR-208 as a biomarker of myocardial injury. Clin. Chem. 55, 1944-1949 (2009).
90. Elmen, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899 (2008).
91. Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201 (2010).